Comparing two ways to give CDR132L in healthy volunteers
Treatments studied
Part of Heart & circulation clinical trials.
This study measures how well the drug CDR132L enters the blood when injected under the skin, compared to injection into a vein. It is done in healthy volunteers to find the best way to give the drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 55 years old.
- Your body mass index (BMI) is between 18.5 and 29.9, and you weigh less than 120 kilograms (about 265 pounds).
- You are generally healthy, with no major heart, kidney, blood, or brain conditions.
- You have normal blood pressure, heart rate, and heart rhythm (confirmed by screening tests).
- Your blood and urine lab results are within a normal range (checked during screening).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called CDR132L to see if it improves heart structure and function in people with heart failure who have a thickened heart muscle and reduced pumping ability. Participants will be randomly assigned to receive either the study drug or a placebo.
This study tests an experimental medicine, CDR132L, to see if it can improve heart structure and function in people with a type of heart failure where the heart muscle is thickened. If you have heart failure with normal pumping function and thickened heart walls, this trial may offer access to a new potential treatment.
This study tests a new medicine called NNC0705-0002 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This study gives healthy volunteers a small, safe dose of a radiolabeled (radioactive) drug to see how it is absorbed, broken down, and removed from the body. By participating, you help researchers understand the drug's behavior, which informs future dosing and safety.
This study tests an investigational drug in healthy male volunteers to see how the body absorbs and processes it. Participation may help provide important safety info for future patients, and you will be closely monitored by medical staff.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.